Skadden has advised Waldencast. Waldencast has entered into a definitive agreement to sell its Obagi Medical skincare and aesthetics business to Bridgepoint for up to $460...
Waldencast to Sell Obagi Medical to Bridgepoint in $460 Million Transaction
New Fortress Energy Enters UK Restructuring Plan with Creditors
Skadden has advised New Fortress Energy Inc. New Fortress Energy Inc. has entered into a Restructuring Support Agreement (RSA) with its creditors as part of a...
Citi Sells 24% Stake in Banamex to Institutional Investors and Family Offices
Skadden, White & Case, and Creel, García-Cuéllar, Aiza y Enríquez have advised Citi. Citi has entered into agreements with a consortium of prominent institutional investors and...
Fernando Chico Pardo Acquires 25% Stake in Banamex from Citi for $2.3 Billion
Paul, Weiss, Rifkind, Wharton & Garrison and Bufete Robles Miaja have advised Fernando Chico Pardo and his family. Skadden, Creel, García-Cuéllar, Aiza y Enríquez, and White...
FinVolution Group Completes US$150 Million Convertible Senior Notes Offering
Skadden has advised FinVolution Group. FinVolution Group has completed a US$150 million offering of convertible senior notes due 2030. The offering marks a significant financing initiative...
Waldencast Acquires Novaestiq and U.S. Rights to Saypha Injectable Gel Line
Skadden and Holland & Knight have advised Waldencast plc. Waldencast plc, a global multi-brand beauty and wellness platform, has acquired Novaestiq Corp., a company specializing in...
XenoTherapeutics to Acquire ESSA Pharma in All-Cash Agreement Backed by XOMA Royalty
Skadden, Arps, Slate, Meagher & Flom LLP, alongside Blake, Cassels & Graydon LLP, have advised ESSA Pharma Inc. Stikeman Elliott LLP and Gibson, Dunn & Crutcher...
Alcon Announces Acquisition of LumiThera and Photobiomodulation Device for Dry AMD
Skadden has advised Alcon. Alcon has announced its intention to acquire LumiThera, Inc., a company recognized for its light-based innovations in ophthalmology, along with its photobiomodulation...
BioCryst Sells European ORLADEYO® Business to Neopharmed Gentili for Up to $264 Million
Skadden has advised BioCryst Pharmaceuticals, Inc., White & Case has advised Neopharmed Gentili. BioCryst Pharmaceuticals, Inc. has announced the execution of a definitive agreement for the...
TTAM Research Institute’s $305 Million Acquisition of 23andMe
Paul, Weiss, Rifkind, Wharton & Garrison and Carmody MacDonald have advised 23andMe Holding Co.; Skadden, Kirkland & Ellis, Arnold & Porter Kaye Scholer, and Quinn Emanuel...
Jazz Pharmaceuticals’ $935 Million Acquisition of Chimerix
Wachtell, Lipton, Rosen & Katz is serving as legal advisor to Jazz, while Skadden and Cooley are advising Chimerix on the deal. Jazz Pharmaceuticals plc and...
Emerson’s $7.2 Billion Acquisition of Remaining Outstanding Shares of AspenTech
Davis Polk & Wardwell is serving as legal advisor to Emerson, while Skadden, Arps, Slate, Meagher & Flom is serving as legal counsel to the AspenTech...